2021 lookout, page-18

Cov data may currently be gathered and awaiting assesment ...A Feasibility Trial Using Trevalan in Healthy Volunteers for Increasing an in Vitro Immune Response to COVID-19 Proteins

Study Design

Go to

	Study Type:	Interventional (Clinical Trial)
1	EstimatedEnrollment:	5 participants
2	Allocation:	N/A
3	Intervention Model:	Single Group Assignment
4	Masking:	None (Open Label)
5	Primary Purpose:	Other
6	Official Title:	A Feasibility Trial Using Trevalan in Healthy Volunteers for Increasing an in Vitro Immune Response to COVID-19 Proteins
7	ActualStudy Start Date:	November 1, 2020
8	EstimatedPrimary Completion Date:	December 31, 2020
9	EstimatedStudy Completion Date:	December 31, 2020